Literature DB >> 14638651

Antiviral treatment of SARS: can we draw any conclusions?

Getu Zhaori1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14638651      PMCID： PMC264956     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Ribavirin in the treatment of SARS: A new trick for an old drug?

Authors:  Gideon Koren; Susan King; Sandra Knowles; Elizabeth Phillips
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

2.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

3.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

4.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

5.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

6.  Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China.

Authors:  Z Zhao; F Zhang; M Xu; K Huang; W Zhong; W Cai; Z Yin; S Huang; Z Deng; M Wei; J Xiong; P M Hawkey
Journal:  J Med Microbiol       Date:  2003-08       Impact factor: 2.472

7.  Identification and containment of an outbreak of SARS in a community hospital.

Authors:  Hy A Dwosh; Harry H L Hong; Douglas Austgarden; Stanley Herman; Richard Schabas
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

8.  Clinical course and management of SARS in health care workers in Toronto: a case series.

Authors:  Monica Avendano; Peter Derkach; Susan Swan
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

9.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

10.  Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts.

Authors:  Li-Yang Hsu; Cheng-Chuan Lee; Justin A Green; Brenda Ang; Nicholas I Paton; Lawrence Lee; Jorge S Villacian; Poh-Lian Lim; Arul Earnest; Yee-Sin Leo
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883
View more
  10 in total

1.  The psychological impact of SARS: a matter of heart and mind.

Authors:  Kang Sim; Hong Choon Chua
Journal:  CMAJ       Date:  2004-03-02       Impact factor: 8.262

Review 2.  Development of novel entry inhibitors targeting emerging viruses.

Authors:  Yanchen Zhou; Graham Simmons
Journal:  Expert Rev Anti Infect Ther       Date:  2012-10       Impact factor: 5.091

Review 3.  Treatment of severe acute respiratory syndrome.

Authors:  S T Lai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

Review 4.  Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.

Authors:  C W Leung; W K Chiu
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

5.  Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.

Authors:  Masayuki Saijo; Shigeru Morikawa; Shuetsu Fukushi; Tetsuya Mizutani; Hideki Hasegawa; Noriyo Nagata; Naoko Iwata; Ichiro Kurane
Journal:  Antiviral Res       Date:  2005-02-19       Impact factor: 5.970

Review 6.  Treatment and vaccines for severe acute respiratory syndrome.

Authors:  David A Groneberg; Susan M Poutanen; Donald E Low; Hartmut Lode; Tobias Welte; Peter Zabel
Journal:  Lancet Infect Dis       Date:  2005-03       Impact factor: 25.071

7.  Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.

Authors:  Hsueh-Erh Chiou; Ching-Lung Liu; Mary Jeanne Buttrey; Han-Pin Kuo; Hui-Wen Liu; Hsu-Tah Kuo; Yen-Ta Lu
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

8.  In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.

Authors:  Els Keyaerts; Leen Vijgen; Piet Maes; Johan Neyts; Marc Van Ranst
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575

9.  HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.

Authors:  Norio Yamamoto; Rongge Yang; Yoshiyuki Yoshinaka; Shinji Amari; Tatsuya Nakano; Jindrich Cinatl; Holger Rabenau; Hans Wilhelm Doerr; Gerhard Hunsmann; Akira Otaka; Hirokazu Tamamura; Nobutaka Fujii; Naoki Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2004-06-04       Impact factor: 3.575

10.  Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.

Authors:  Els Keyaerts; Leen Vijgen; Luni Chen; Piet Maes; Göran Hedenstierna; Marc Van Ranst
Journal:  Int J Infect Dis       Date:  2004-07       Impact factor: 3.623
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.